Comparison of the anaesthetic efficacy and safety of different doses of esketamine combined with propofol in hysteroscopic surgery: a randomised, double-blind controlled trial.
- 1Department of Anesthesiology, Wenzhou People's Hospital, 57 Canghou Street, Wenzhou, 325000, Zhejiang, China.
- 2Department of Anesthesiology, Wenzhou People's Hospital, 57 Canghou Street, Wenzhou, 325000, Zhejiang, China. [email protected].
Abstract
Background
Hysteroscopy is increasingly performed under day-surgery total intravenous anaesthesia, but propofol alone provides insufficient analgesia and the routine adjunct of opioids is associated with respiratory depression and emetic complications. Esketamine, the S-enantiomer of ketamine, offers analgesia together with sympathomimetic support and represents a promising opioid-sparing alternative; however, its optimal dose for combination with propofol in this setting has not been firmly established.Methods
In this prospective, randomised, double-blind, controlled trial, 160 women aged 18-60 years (ASA I-II) scheduled for elective hysteroscopy were assigned to four groups using computer-generated random numbers: K1 (esketamine 0.15 mg/kg), K2 (esketamine 0.3 mg/kg), K3 (esketamine 0.5 mg/kg) or S (sufentanil 0.1 µg/kg). All patients received an induction dose of propofol 1.5 mg/kg followed by maintenance infusion of 4-6 mg·kg⁻¹·h⁻¹. The primary outcomes were postoperative pain (Numeric Rating Scale, NRS) and total intra-operative propofol consumption; secondary outcomes were perioperative haemodynamics, recovery time and adverse events. After exclusion of three patients with major protocol deviation, 157 patients were analysed (K1 = 40, K2 = 38, K3 = 40, S = 39).Results
Demographics, surgical and anaesthesia times were comparable between groups. NRS scores at 10 and 30 min post-recovery were significantly lower in groups K2, K3 and S than in group K1 (p < 0.001). Mean arterial pressure at the start of surgery (T2, immediately after the start of surgery) and at the end of surgery (T3) was significantly higher in K1 than in the other three groups (p < 0.001). Total propofol consumption did not differ between groups (p = 0.95). The incidence of intra-operative hypertension was significantly greater in K1 (22.5%) than in K2 (0%), K3 (5.0%) and S (5.1%) (p = 0.002), and the incidence of SpO₂ < 90% was significantly greater in S (20.5%) than in K1 (0%), K2 (5.3%) and K3 (5.0%) (p = 0.004). The incidence of emergence agitation differed among groups, with the highest incidence observed in K3 (10.0%) (p = 0.034).Conclusions
Among the regimens tested, esketamine 0.3 mg/kg combined with propofol 1.5 mg/kg was associated with a favourable balance of analgesia, haemodynamic stability and safety. The 0.15 mg/kg dose was associated with higher postoperative pain scores and a higher incidence of intra-operative hypertension, while 0.5 mg/kg was associated with a higher incidence of agitation and a longer recovery time without additional analgesic benefit at 30 min. All three esketamine doses were associated with a lower incidence of hypoxaemia than the sufentanil regimen.Clinical register number
The trial was registered in the Chinese Clinical Trial Registry (ChiCTR2400092022) with the retrospective registration date 2024/11/07.
Related
- Comparison of Postoperative Analgesic Efficacy Between Opioid-free Anaesthesia Using Intravenous Magnesium, Lidocaine, and Erector Spinae Plane Block, and Opioid-based Anaesthesia in Laparoscopic Abdominal Surgeries: A Randomised Controlled Trial
- Comparison of ‘quilting sutures’ with ‘conventional sutures and drain placement’ after mastectomy: protocol for the BE-Quilt – a multicentre, pragmatic randomised controlled trial
- Effect of Adding Esketamine to Patient-Controlled Intravenous Analgesia on Rebound Pain After Interscalene Brachial Plexus Block: A Randomized Controlled Trial
- Dual benefit of esketamine-based opioid-free anesthesia on postoperative pain and mental health outcomes in patients undergoing bariatric surgery: a randomized controlled trial.
- Clinical Effects of Low-Dose Esketamine During Emergency Conversion From Labor Epidural Analgesia to Category I Cesarean Section: A Randomized Controlled Trial of Maternal Hemodynamics, Analgesia, Sedation, and Neonatal Outcomes
BibTeX
@article{li2026comparison,
title = {{Comparison of the anaesthetic efficacy and safety of different doses of esketamine combined with propofol in hysteroscopic surgery: a randomised, double-blind controlled trial.}},
author = {Ruru Li and Zhanghuan Chi and Jing Chen and Juncheng Xiong and Yanya Zheng},
journal = {BMC anesthesiology},
year = {2026},
month = jul,
doi = {10.1186/s12871-026-04119-w},
url = {https://europepmc.org/article/MED/42968012},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Comparison of the anaesthetic efficacy and safety of different doses of esketamine combined with propofol in hysteroscopic surgery: a randomised, double-blind controlled trial.
AU - Ruru Li
AU - Zhanghuan Chi
AU - Jing Chen
AU - Juncheng Xiong
AU - Yanya Zheng
PY - 2026
DA - 2026/07/28
JO - BMC anesthesiology
DO - 10.1186/s12871-026-04119-w
UR - https://europepmc.org/article/MED/42968012
AB - Background Hysteroscopy is increasingly performed under day-surgery total intravenous anaesthesia, but propofol alone provides insufficient analgesia and the routine adjunct of opioids is associated with respiratory depression and emetic complications. Esketamine, the S-enantiomer of ketamine, offers analgesia together with sympathomimetic support and represents a promising opioid-sparing alternative; however, its optimal dose for combination with propofol in this setting has not been firmly established.Methods In this prospective, randomised, double-blind, controlled trial, 160 women aged 18-60 years (ASA I-II) scheduled for elective hysteroscopy were assigned to four groups using computer-generated random numbers: K1 (esketamine 0.15 mg/kg), K2 (esketamine 0.3 mg/kg), K3 (esketamine 0.5 mg/kg) or S (sufentanil 0.1 µg/kg). All patients received an induction dose of propofol 1.5 mg/kg followed by maintenance infusion of 4-6 mg·kg⁻¹·h⁻¹. The primary outcomes were postoperative pain (Numeric Rating Scale, NRS) and total intra-operative propofol consumption; secondary outcomes were perioperative haemodynamics, recovery time and adverse events. After exclusion of three patients with major protocol deviation, 157 patients were analysed (K1 = 40, K2 = 38, K3 = 40, S = 39).Results Demographics, surgical and anaesthesia times were comparable between groups. NRS scores at 10 and 30 min post-recovery were significantly lower in groups K2, K3 and S than in group K1 (p < 0.001). Mean arterial pressure at the start of surgery (T2, immediately after the start of surgery) and at the end of surgery (T3) was significantly higher in K1 than in the other three groups (p < 0.001). Total propofol consumption did not differ between groups (p = 0.95). The incidence of intra-operative hypertension was significantly greater in K1 (22.5%) than in K2 (0%), K3 (5.0%) and S (5.1%) (p = 0.002), and the incidence of SpO₂ < 90% was significantly greater in S (20.5%) than in K1 (0%), K2 (5.3%) and K3 (5.0%) (p = 0.004). The incidence of emergence agitation differed among groups, with the highest incidence observed in K3 (10.0%) (p = 0.034).Conclusions Among the regimens tested, esketamine 0.3 mg/kg combined with propofol 1.5 mg/kg was associated with a favourable balance of analgesia, haemodynamic stability and safety. The 0.15 mg/kg dose was associated with higher postoperative pain scores and a higher incidence of intra-operative hypertension, while 0.5 mg/kg was associated with a higher incidence of agitation and a longer recovery time without additional analgesic benefit at 30 min. All three esketamine doses were associated with a lower incidence of hypoxaemia than the sufentanil regimen.Clinical register number The trial was registered in the Chinese Clinical Trial Registry (ChiCTR2400092022) with the retrospective registration date 2024/11/07.
SN - 1471-2253
ER -